Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease - A preliminary study

Thrombosis and Haemostasis

Volumn 76, Issue 4, 1996, Pages 523-528

  Iversen, L H ^a   Okholm, M ^b   Thorlacius Ussing, O ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN DEGRADATION PRODUCT; PROTHROMBIN; THROMBIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD CLOTTING; CANCER SURGERY; COLORECTAL CANCER; COLORECTAL DISEASE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FIBRINOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; PLASMA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0029806415     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650616     Document Type: Article

References (29)

1. Edwards RL, Rickles FR, Moritz TE, Henderson WC, Zacharski LR, Forman WB, Cornell CJ, Forcier RJ, O'Donnell JF, Headley E et al. Abnormalities of blood coagulation tests in patients with cancer. Am J Clin Pathol 1987; 88: 596-602.
2. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992; 11: 237-48.
3. Rahr HB, Sørensen JV. Venous thromboembolism and cancer. Blood Coagul Fibrinolysis 1992; 3: 451-60.
4. Bounameaux H, Huber O, Khabiri E, Schneider PA, Didier D, Rohner A. Unexpectedly high rate of phlebographic deep venous thrombosis following elective general abdominal surgery among patients given prophylaxis with low-molecular-weight heparin. Arch Surg 1993; 128: 326-8.
5. Bergqvist D, Burmark US, Flordal PA, Frisell J, Hallbook T, Hedberg M, Horn A, Kelty E, Kvitting P, Lindhagen A et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xal units in 2070 patients. Br J Surg 1995; 82: 496-501.
6. Wiig JN, Solhaug JH, Bilberg T, Bjerkeset T, Edwin B, Grüner OP, Havig Y, Holter O, Knudsen G, Lundblad R et al. Prophylaxis of venographically diagnosed deep vein thrombosis in gastrointestinal surgery. Multicenter trials 20 mg and 40 mg Enoxaparin versus dextran. Eur J Surg 1995; 161: 663-8.
7. Falanga A, Barbui T, Rickles FR, Levine MN. Guidelines for clotting studies in cancer patients. For the Scientific and Standardization Committee of the Subcommittee on Haemostasis and Malignancy International Society of Thrombosis and Haemostasis. Thromb Haemost 1993; 70: 540-2.
8. Iversen LH, Thorlacius-Ussing O, Okholm M. Soluble fibrin in plasma before and after surgery for benign and malignant colorectal disease. Thromb Res 1995; 79: 471-81.
9. Falanga A, Ofosu FA, Cortelazzo S, Delaini F, Consonni R, Caccia R, Longatti S, Maran D, Rodeghiero F, Pogliani E et al. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery. Br J Haematol 1993; 85: 745-50.
10. Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972; 104: 134-44.
11. Pelzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991; 65: 153-9.
12. Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-amithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59: 101-6.
13. Koopman J, Haverkate F, Koppert P, Nieuwenhuizen W, Brommer EJ, Van der Werf WG. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody. J Lab Clin Med 1987; 109: 75-84.
14. Armitage P, Berry G. In: Statistical methods in medical research. Second ed. Blackwell Scientific Publications, London 1987.
15. Miettinen OS. Simple interval-estimation of risk ratio. [Abstract] Am J Epidemiol 1974; 100: 515-6.
16. Zacharski LR, Wojtukiewicz MZ, Costantini V, Ornstein DL, Memoli VA. Pathways of coagulation/fibrinolysis activation in malignancy. Semin Thromb Hemost 1992; 18: 104-16.
17. van Duijnhoven EM, Lustermans FA, van Wersch JW. Evaluation of the coagulation/fibrinolysis balance in patients with colorectal cancer. Haemostasis 1993; 23: 168-72.
18. Edwards CM, Warren J, Armstrong L, Donnelly PK. D-dimer: a useful marker of disease stage in surgery for colorectal cancer. Br J Surg 1993; 80: 1404-5.
19. McCulloch P, Nieuwenhuizen W, Douglas J, Lowe GD, George WD. Coagulation disturbances in cancer of the breast and colon measured with specific monoclonal antibody enzyme immunoassay for fibrin-fibrinogen degradation products. Haemostasis 1990; 20: 73-80.
20. Bauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest 1987; 80: 1527-34.
21. Cadroy Y, Pierrejean D, Fontan B, Sié P, Boneu B. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years. Nouv Rev Fr Hematol 1992; 34: 43-6.
22. Hursting MJ, Stead AG, Crout FV, Horvath BZ, Moore BM. Effects of age, race, sex, and smoking on prothrombin fragment 1.2 in a healthy population. Clin Chem 1993; 39: 683-6.
23. Lindahl AK, Boffa MC, Abildgaard U. Increased plasma thrombomodulin in cancer patients. Thromb Haemost 1993; 69: 112-4.
24. van Wersch JW, Peters C, Ubachs HM. Haemiostasis activation markers in plasma of patients with benign and malignant gynaecological tumours: a pilot study. Eur J Clin Chem Clin Biochem 1995; 33: 225-9.
25. Törngren S, Rieger A. Prophylaxis of deep venous thrombosis in colorectal surgery. Dis Colon Rectum 1982; 25: 563-6.
26. Wille Jørgensen P, Ott P. Predicting failure of low-dose prophylactic heparin in general surgical procedures. Surg Gynecol Obstet 1990; 171: 126-30.
27. Wille Jørgensen P, Thorup J, Fischer A, Holst Christensen HJ, Flamsholt R. Heparin with and without graded compression stockings in the prevention of thromboembolic complications of major abdominal surgery: a randomized trial. Br J Surg 1985; 72: 579-81.
28. Pratt CW, Church FC. Antithrombin: structure and function. Semin Hematol 1991; 28: 3-9.
29. Bauer KA, Goodman TL, Kass BL, Rosenberg RD. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency. J Clin Invest 1985; 76: 826-36.